Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alliant Pharmaceuticals

Alliant Pharmaceuticals?uq=w9if130k
2004 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Producer of pediatric pharmaceutical products. The company is engaged in acquiring, developing and commercializing proprietary products for the allergy and immunology, psychiatry, neurology, dermatology, urology, infectious diseases, pediatric and pediatric specialty markets.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 333 North Point Center East
  • Suite 250
  • Alpharetta, GA 30022
  • United States

Alliant Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alliant Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Alliant Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Stresser Chief Financial Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »